|
Donald Hildebrand is a co-founder of GeoVax Labs and has more than 30 years of successful experience managing biotechnology and biopharmaceutical companies. During his career he has led teams developing licensing and commercializing some of the world�s leading vaccines and pharmaceutical products.
As North American President and CEO of Rhone Merieux Inc. Mr. Hildebrand grew the company from a staff of five and no sales to more than 1 100 employees and annual sales exceeding $200 million. When Rhone Merieux merged with Merial Ltd. Mr. Hildebrand was promoted to Global Vice President responsible for research product development technical services and business development of worldwide biological activities. He was a member of Merial�s Executive Committee. Merial is the world�s largest animal health company with annual sales exceeding $2 billion and a $120 million research budget.
Previously Hildebrand founded Biocraft Ltd. which was later sold to Solvay & Cie of Brussels Belgium. Subsequently he became Solvay�s Director of Global Biological Operations Research Development and Manufacturing. This company is currently owned by American Home Products.
Mr. Hildebrand has served on the Board of Directors of Select Laboratories Inc. University of Georgia Research Foundation Vaxin Pharmaceuticals Inc. First American Bancorp of Georgia/First American Bank Rhone Merieux Inc. RM de Mexico Inc. RM Technologies Inc. Biocraft Ltd. University of Wisconsin SCVM Board of Visitors and the Athens Ga. Economic Development Foundation.
Hildebrand has a Microbiology degree from the University of Wisconsin-Madison and has taken advanced management courses at Harvard Business School and Marquette University.
| 